TOP TIERMARKET NEWSWIRE
News & sentiment

SCINAI IMMUNOTHERAPE ADR (SCNI) — News & AI sentiment

SCINAI IMMUNOTHERAPE ADR (SCNI) news roundup. 3 stories in the past week, 8 over 30 days. Average 30-day sentiment is 56.8/100. No insider transactions filed in the last 90 days. No congressional trade disclosures in the last 90 days. Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →
24h stories
0
7d stories
3
avg sentiment 62.3/100
30d stories
8
avg sentiment 56.8/100
Insider net (90d)
$0
0 buys · 0 sells
Congress (90d)
0
0 buys · 0 sells

SCNI news in the last 24 hours, 7 days, 30 days and 90 days

How much SCNI coverage the wire captured in each window, with the average AI sentiment across those stories. Counts are of stories that have cleared the 4-hour public delay.

Time windowSCNI storiesAvg AI sentimentRead
Last 24 hours0—no coverage
Last 7 days362.3/100SCNI headlines →
Last 30 days856.8/100SCNI headlines →
Last 90 days1255/100SCNI headlines →

Latest stories on SCNI

3d ago
3d ago
3d ago
Sep 8
Sep 8
Sep 8
Aug 26
Aug 26
Scinai Immunotherapeutics reports 1H results
Seeking Alpha50 · neutralgeneral
Aug 24
Aug 24
Aug 20
Aug 10
Jun 15
Scinai Immunotherapeutics reports Q1 results
Seeking Alpha50 · neutralearnings
Jun 10
Jun 10
May 20
May 15
Open SCNI in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →